HIMS: Hims & Hers Health, Inc. Stock

by  •  • Comments Off on HIMS: Hims & Hers Health, Inc. Stock

SIC 8011 – Offices and Clinics of Doctors of Medicine

Valuation
Market Cap ($M) 4,578.11
Enterprise Value ($M) 4,412.59
Book Value ($M) 440.05
Book Value / Share 2.09
Price / Book 10.40
NCAV ($M) 164.16
NCAV / Share 0.78
Price / NCAV 27.89

Profitability (mra)
Return on Invested Capital (ROIC) 0.22
Return on Assets (ROA) 0.24
Return on Equity (ROE) 0.31

Liquidity (mrq)
Quick Ratio 1.82
Current Ratio 2.14

Balance Sheet (mrq) ($M)
Current Assets 326.38
Assets 602.26
Liabilities 162.21
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
11-12 13G/A Vanguard Group Inc 8.73 0.00
11-07 13G/A BlackRock, Inc. 14.20 92.14
10-25 13D/A Dudum Andrew 11.10 -8.35
05-22 13D/A Institutional Venture Management XVI, LLC 3.60 -41.71
02-14 13G/A Abraham Jack 4.60 -21.93

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-04 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended September 30, 2024 ☐ TRANSITION REPORT PURSUANT
2024-08-05 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended June 30, 2024 ☐ TRANSITION REPORT PURSUANT TO S
2024-05-06 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Quarterly Period Ended March 31, 2024 ☐ TRANSITION REPORT PURSUANT TO
2024-02-26 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2023 ☐ TRANSITION REPORT PURSUANT TO SECTI

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-11-21 6,794,496 22,287,181 30.49
2024-11-20 4,838,292 17,313,602 27.95
2024-11-19 5,933,211 21,400,436 27.72
2024-11-18 6,302,591 22,062,383 28.57

(click for more detail)

Similar Companies
TDOC – Teladoc Health, Inc.


Financial data and stock pages provided by
Fintel.io